Gimlet Labs, Inc. | $80,000,000 | (Mar 26, 2026)
Highlight(US) | $40,000,000 | (Mar 26, 2026)
BrainGrid | $1,000,000 | (Mar 26, 2026)
Deep Apple Therapeutics
United States
- San Francisco Bay Area
- 18/12/2023
- Series A
- $52,000,000
In a vast, unexplored virtual chemical space, Deep Apple Therapeutics moves with unprecedented speed to discover novel small molecules for high-value targets. Deep Apple combines ensemble cryo-EM to explore receptor conformations; deep learning; and the docking of multi-billion compound libraries generated using the company's proprietary Orchard.ai™ algorithm. Deep Apple's deep learning discovery engine is built upon founder expertise in computational modeling, protein and target structure determination, large-scale molecular docking, and the elucidation of protein dynamics and conformational transitions. This structure-based, machine-learning driven drug design approach enables the company to rapidly advance novel candidates addressing well-validated targets in inflammatory, metabolic, and endocrine diseases. For more information, visit deepappletx.com.
- Industry Biotechnology Research
- Website https://deepappletx.com/
- LinkedIn https://www.linkedin.com/company/deep-apple-therapeutics/about/
NOPALERA | $4,000,000 | (Mar 26, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Worth AI | $30,000,000 | (Mar 26, 2026)
Moda | $7,500,000 | (Mar 26, 2026)
Miraterra Technologies Corporation | $11,566,320 | (Mar 26, 2026)
Hanover Park | $27,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)
Talino Fintech Foundry | $7,500,000 | (Mar 26, 2026)
Doctronic | $40,000,000 | (Mar 26, 2026)